FDA approves Ofev for the treatment of scleroderma
By NewsDesk @infectiousdiseasenews On Friday, the U.S. Food and Drug Administration approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease More...